Addressing rural care is a way of addressing health inequities, and the Biden administration’s recent investment in rural care reflects its commitment to addressing health equity, said Ryan Urgo, MPAP, managing director, health policy, Avalere.
Addressing rural care is a way of addressing health inequities, and the Biden administration’s recent investment in rural care reflects its commitment to addressing health equity, said Ryan Urgo, MPAP, managing director, health policy, Avalere.
Transcript
There is a rural health care push from the Biden administration. What is the commitment from the administration and what problems is it hoping to address?
Well, without a doubt, I would say that addressing rural health care is a health equity issue. You often see unequal outcomes in rural communities, disproportionately poor access to care and access to providers, and I think the Biden [administration’s] emphasis on rural health care is a reflection of their commitment to addressing health equity. I think the two are inextricably linked.
I also think that telehealth and a lot of the telehealth improvements you've seen over the course of the pandemic is a way to improve health care in rural communities, because you can bring health care to places where the bricks and mortar presence is just not what it is in more urban centers.
Does the Medicare waiver for telehealth that was enacted as part of the public health emergency (PHE) need to be extended beyond the PHE by regulatory or legislative action?
Telehealth is such a broad and umbrella term that it could be a little bit of both. But certainly there are regulatory means through which some of the expiring telehealth flexibilities could be extended. And that's going to be a hot topic for supporters of telehealth, is to assess: what's set to expire and what isn’t? And how can how can some of those expiring flexibilities be preserved through ongoing regulation?
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More